Related references
Note: Only part of the references are listed.Aberrant DNA hypermethylation signature in acute myeloid leukemia directed by EVI1
Sanne Lugthart et al.
BLOOD (2011)
Frequent EVI1 translocations in myeloid blast crisis CML that evolves through tyrosine kinase inhibitors
Ronald L. Paquette et al.
CANCER GENETICS (2011)
EVI-1 oncogene expression predicts survival in chronic-phase CML patients resistant to imatinib treated with second-generation tyrosine kinase inhibitors
Mustafa Daghistani et al.
BLOOD (2010)
Optimising chronic myeloid leukaemia therapy in the face of resistance to tyrosine kinase inhibitors - A synthesis of clinical and laboratory data
David A. Irvine et al.
BLOOD REVIEWS (2010)
Standard treatment of Ph+ CML in 2010: how, when and where not to use what BCR/ABL1 kinase inhibitor?
Peter Valent
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
Ex Vivo Expansion of Retrovirally Transduced Primate CD34+Cells Results in Overrepresentation of Clones With MDS1/EVI1 Insertion Sites in the Myeloid Lineage After Transplantation
Stephanie Sellers et al.
MOLECULAR THERAPY (2010)
Chronic myeloid leukemia in blast phase associated with t(3;8)(q26;q24)
Pei Lin et al.
CANCER GENETICS AND CYTOGENETICS (2009)
High EVI1 levels predict adverse outcome in acute myeloid leukemia:: prevalence of EVI1 overexpression. and chromosome 3q26 abnormalities underestimated
Sanne Lugthart et al.
BLOOD (2008)
EVII activation in blast crisis CML due to juxtaposition to the rare 17q22 partner region as part of a 4-way variant translocation t(9;22)
An De Weer et al.
BMC CANCER (2008)
Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells
Susumu Goyama et al.
CELL STEM CELL (2008)
Gene expression analysis of BCR/ABLI-dependent transcriptional response reveals genes involved in negative enrichment for feedback regulation
Petra Hikansson et al.
GENES CHROMOSOMES & CANCER (2008)
The oncogene and developmental regulator EVI1: Expression, biochemical properties, and biological functions
Rotraud Wieser
GENE (2007)
Identification and functional signature of genes regulated by structurally different ABL kinase inhibitors
K. Nunoda et al.
ONCOGENE (2007)
Chronic myeloid leukaemia as a model of disease evolution in human cancer
Junia V. Melo et al.
NATURE REVIEWS CANCER (2007)
cDNA microarray study to identify expression changes relevant for apoptosis in K562 cells co-treated with amifostine and imatinib
Michele Bianchini et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Conservation and expression of a novel alternatively spliced Evi1 exon
Hadi Alzuherri et al.
GENE (2006)
Targeted CML therapy: controlling drug resistance, seeking cure
T O'Hare et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2006)
Regulation of the expression of the oncogene EVI1 through the use of alternative mRNA 5′-ends
M Aytekin et al.
GENE (2005)
Lonafarnib reduces the resistance of primitive quiescent CML cells to imatinib mesylate in vitro
HG Jorgensen et al.
LEUKEMIA (2005)
Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression
H Yuasa et al.
EMBO JOURNAL (2005)
Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking
O Kustikova et al.
SCIENCE (2005)
Myeloid/natural killer cell blast crisis representing an additional translocation, t(3;7)(q26;q21) in Philadelphia-positive chronic myelogenous leukemia
H Henzan et al.
ANNALS OF HEMATOLOGY (2004)
Translocation t(2;3)(p15-23;q26-27) in myeloid malignancies: report of 21 new cases, clinical, cytogenetic and molecular genetic features
M Stevens-Kroef et al.
LEUKEMIA (2004)
High EVI1 expression predicts poor survival in acute myeloid leukemia:: a study of 319 de novo AML patients
SBV van Doorn-Khosrovani et al.
BLOOD (2003)
Expression of the TEL/EVI1 fusion transcript in a patient with chronic myelogenous leukemia with t(3;12)(q26;p13)
Y Nakamura et al.
AMERICAN JOURNAL OF HEMATOLOGY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
